{
  "docId": "019de071-753f-7227-aa1d-36a319c59353",
  "docSlug": "7013d0966bfedd0d757b9fa24a480455",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 34,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "other",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The diagram uses a circular flow representing different therapeutic modalities (Immune engagers, Cell therapy, Oncolytic virus, Immuno-oncology, DNA damage response, Antibody drug conjugates, Radioimmuno-conjugates, Nanomedicines, Epigenetics).",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/6",
  "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353",
  "deckJsonHref": "/decks/019de071-753f-7227-aa1d-36a319c59353.json",
  "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.6,
        "x": 0.35,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Circular therapeutic mechanism diagram",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c648691-00d2-4853-9362-f1e0a993178a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.25,
        "x": 0.08,
        "y": 0.2
      },
      "kind": "image",
      "text": "ENHERTU, IMFINZI, Lynparza, TAGRISSO, CALQUENCE",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6982aae-b02f-445b-86f3-f2df3169704f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.04,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source: AstraZeneca.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee7d4bfd-6846-464b-819e-741f6b99c99f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Comprehensive portfolio to combat cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd3789c8-58df-4db8-930e-15138e7586e6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "40d56341-ae02-4378-8fac-38676036179a",
      "evidence": "Circular flow diagram showing therapeutic mechanisms",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 6,
      "beatId": "bc526df6-0425-4b12-88a3-db493ea6a117",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Introduction to cancer treatment challenges and Enhertu's potential",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 17,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31",
      "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.",
      "position": 0,
      "objective": "What are the consequences of not adopting Enhertu as the standard of care?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}